Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
THL-P in refractory metastatic breast cancer
ChiCTR-TRC-11001834Phase 2Completed
- Sponsor
- THL Enterprise
- Start
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of orlistat in breast cancer (2 arms), sponsored by THL Enterprise. Primary endpoints: Efficacy profile and Safety and tolerability. Started Jun 2009; status: completed.
02
Drugs
orlistat
03
Conditions
breast cancer
Beyond the preview
Go deeper on ChiCTR-TRC-11001834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-11001834.